Abstract

Humans have the capacity to evaluate the success of cognitive processes, known as metacognition. Convergent evidence supports a role for anterior prefrontal cortex in metacognitive judgements of perceptual processes. However, it is unknown whether metacognition is a global phenomenon, with anterior prefrontal cortex supporting metacognition across domains, or whether it relies on domain-specific neural substrates. To address this question, we measured metacognitive accuracy in patients with lesions to anterior prefrontal cortex (n = 7) in two distinct domains, perception and memory, by assessing the correspondence between objective performance and subjective ratings of performance. Despite performing equivalently to a comparison group with temporal lobe lesions (n = 11) and healthy controls (n = 19), patients with lesions to the anterior prefrontal cortex showed a selective deficit in perceptual metacognitive accuracy (meta-d'/d', 95% confidence interval 0.28-0.64). Crucially, however, the anterior prefrontal cortex lesion group's metacognitive accuracy on an equivalent memory task remained unimpaired (meta-d'/d', 95% confidence interval 0.78-1.29). Metacognitive accuracy in the temporal lobe group was intact in both domains. Our results support a causal role for anterior prefrontal cortex in perceptual metacognition, and indicate that the neural architecture of metacognition, while often considered global and domain-general, comprises domain-specific components that may be differentially affected by neurological insult.

Highlights

  • Humans have a capacity to evaluate the success of cognitive processes, known as metacognition (Metcalfe, 1996)

  • In the memory task greater study time led to significant increases of performance [F(2,68) = 13.9, P 5 0.0001] and confidence [F(2,68) = 46.1, P 5 0.0001] neither of which interacted with group

  • We found no evidence for perceptual metacognitive deficits in the temporal lobe group compared to healthy control subjects [t(28) = 0.74, P = 0.47]

Read more

Summary

Introduction

Humans have a capacity to evaluate the success of cognitive processes, known as metacognition (Metcalfe, 1996). Impairments in metacognition are found in a range of clinical syndromes, including traumatic brain injury, Alzheimer’s disease, schizophrenia and drug addiction (for reviews see Pannu et al, 2005; Goldstein et al, 2009; David et al, 2012; Cosentino, 2014) In these conditions, impaired awareness of deficits is linked to reduced engagement in remediation treatment, poor adherence to medication and impaired management of functional difficulties (Goldstein et al, 2009; Medley and Powell, 2010; Carretti et al, 2011; Cosentino, 2014).

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.